-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Werewolf Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2024.
- Werewolf Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$15.3M, a 54.5% decline year-over-year.
- Werewolf Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$32.6M, a 19.7% increase from 2022.
- Werewolf Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$40.6M, a 5.32% increase from 2021.
- Werewolf Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$42.9M, a 130% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)